Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Toll Brothers Inc. (TOL) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Toll Brothers Inc. (TOL) - free report >>
Image: Shutterstock
Best Momentum Stocks to Buy for March 7th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 7:
Toll Brothers, Inc. (TOL - Free Report) : This luxury home builder company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 11% over the last 60 days.
Toll Brothers Inc. Price and Consensus
Toll Brothers Inc. price-consensus-chart | Toll Brothers Inc. Quote
Toll Brothers' shares gained 27.2% over the last three months compared with the S&P 500’s advance of 8%. The company possesses a Momentum Score of A.
Toll Brothers Inc. Price
Toll Brothers Inc. price | Toll Brothers Inc. Quote
DemantA/S (WILYY - Free Report) : This hearing healthcare and audio technology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.9% over the last 60 days.
Demant A/S Unsponsored ADR Price and Consensus
Demant A/S Unsponsored ADR price-consensus-chart | Demant A/S Unsponsored ADR Quote
Demant's shares gained 27.7% over the last three months compared with the S&P 500’s advance of 8%. The company possesses a Momentum Score of A.
Demant A/S Unsponsored ADR Price
Demant A/S Unsponsored ADR price | Demant A/S Unsponsored ADR Quote
LeMaitre Vascular, Inc. (LMAT - Free Report) : This vascular medical device company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.3% over the last 60 days.
LeMaitre Vascular, Inc. Price and Consensus
LeMaitre Vascular, Inc. price-consensus-chart | LeMaitre Vascular, Inc. Quote
LeMaitre Vascular's shares gained 24% over the last three months compared with the S&P 500’s advance of 8%. The company possesses a Momentum Score of A.
LeMaitre Vascular, Inc. Price
LeMaitre Vascular, Inc. price | LeMaitre Vascular, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.